Manage Your Liver
Q:

I was diagnosed with chronic hepatitis C, but I don’t feel any abnormalities and my liver function test results are also normal. Why is this? Do I require treatment and what kind?

A:

This phenomenon is actually quite common. Hepatitis C virus (HCV) causes damage to the liver by first evading the immune system and then attacking the liver cells, leading to hepatitis (inflammation of the liver). When liver cells are attacked, liver function will be affected and become abnormal. However, if a person infected with HCV has strong immunity and is able to generate a strong cellular immune response against the virus, the virus will not be able to damage liver cells and affect liver function. [1]

 

People often think that when hepatitis virus is present in the body, the liver will be damaged and that the higher the viral count, the more severe the damage. This is a misconception. The amount of HCV RNA present in blood should not be used to measure the degree of damage in liver cells. A high viral load does not imply serious liver damage, similarly, a low viral count does not equal little liver injury. [2]

 

If patients infected with HCV have normal liver function (regardless of viral load), there is no rationale for treatment. [3][4] (The decision should be made based on taking together all laboratory data and overall health factors such as HCV viral load, liver enzymes, age, etc.) However, patients must ensure and maintain strong immunity and monitor liver health and function by having regular checkups.

 

Patients should pay attention to their ALT & AST levels, as these enzymes are commonly used as indicators of liver injury. When these enzymes are within the normal range, there is a high possibility that liver function is normal. But in some cases, these enzyme levels may also be within the normal range even in the presence of liver damage, e.g. cirrhosis. Therefore, patients should look at the overall results of Liver Function Tests (LFTs) to assess the general state of the liver.

 

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
DAAs (direct-acting antivirals) are the latest hepatitis C treatment option introduced to the market, their high price tag has caused great controversy since their introduction but recently people are worried about something else – DAA’s possible side effects. Recent findings revealed that DAAs could lead to aggressive growth of hepatocellular carcinoma (HCC) or liver cancer. In a Spanish study, investigators noted a "high rate of cancer recurrence" after
A:
Liver cancer is one of the most common cancers in many parts of the world. Worldwide, the most common cause for liver cancer is chronic hepatitis C infection. People infected with the hepatitis virus have a high risk of developing chronic hepatitis, cirrhosis, and ultimately liver cancer. Some other causes for liver cancer include alcohol abuse, diabetes and obesity.   Types of liver cancer There are two types of liver cancer: primary and se
Hit Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
YHK has significant effect in stopping liver inflammation; it can enhance the recovery of liver health and protect liver cells. Those who have experienced YHK often have these questions in mind: Why is YHK so different from other liver medicines and supplements? Why is it possible to have such unprecedented effects? The answer seems magical, but in fact, it is not complicated - Because YHK possesses a perfect balance.   To explain this, we must first point out that YH
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us